The study was funded by LG Chem, Mochida Pharmaceutical, and Korea Health Industry Development Institute. LG Chem employs two of the six study authors, and Mochida Pharmaceutical employs another two.
Reference
- Matsuno H, Tomomitsu M, Hagino A, et al. Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate. Ann Rheum Dis. 2017 Dec 19. pii: annrheumdis-2017-212172. doi: 10.1136/annrheumdis-2017-212172. [Epub ahead of print]